Viewing Study NCT04678102


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-02-28 @ 9:43 PM
Study NCT ID: NCT04678102
Status: UNKNOWN
Last Update Posted: 2023-06-26
First Post: 2020-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module